期刊文献+

奥氮平治疗精神障碍的临床应用 被引量:1

Clinical application of olanzapine in treating mental disoeders
暂未订购
导出
摘要 目的 :了解奥氮平治疗各类精神障碍的用药特点、有效性及不良反应。方法 :调查 12 6例以奥氮平治疗 4周以上住院精神病人。结果 :平均起始剂量 ( 5 .4 6± 3.36 ) mg,平均治疗剂量 ( 10 .11± 4 .5 8) mg,总有效率 5 8.73%。结论 :奥氮平对各种精神障碍有效 ,不良反应少 。 Object: To know the characteristics, efficacy and side-effects of olanzapine in treating various mental disorders. Methods: 126 cases of inpatients with olanzapine treatment more than 4 weeks were investigated. Results: The average initial dosage was (5.46±3.36) mg and the average therapeutic dosage was (10.11±4.58)mg. The total efficacious rate was 58.73%. Conclusion: Olanzapine is efficacious in treating mental disorders .It has fewer side-effects and is suitable for all age patient.
作者 王丽莉 林凯
出处 《天津药学》 2003年第5期20-21,共2页 Tianjin Pharmacy
关键词 奥氮平 精神障碍 疗效 药物治疗 临床应用 olanzapine, mental disorders, efficacy
  • 相关文献

参考文献7

  • 1舒良,刘平,周沫,王希林,张鸿燕,郭俊花,周方,侯也之.奥氮平治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1999,32(4):223-225. 被引量:99
  • 2李华杰,吴爱勤.奥氮平的药理学及临床应用[J].临床精神医学杂志,2001,11(2):114-117. 被引量:109
  • 3赵焕华,尤年兴,晏云兴,狄良宝,管元瑞.奥氮平治疗脑器质性及躯体疾病所致精神障碍的临床分析[J].中华精神科杂志,2001,34(4):225-225. 被引量:21
  • 4Tran P V,Hamiton S H,Kuntz A J, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J clin Psychopharmacol, 1997,17 : 407.
  • 5Stahl S M. Neuropharmacology of obesity:my receptors made me eat it I-BRAINSTOMST. J clin Psychinatry, 1998,59.. 447.
  • 6Sakata T, Fukagawa K, Fujimoto K, et al. Feeding induced by blockade of histamine HI-receptor in rat brain. Experiential, 1988,44:216.
  • 7Oishi R,Shishido S,Yamori M, et al. Comparison of the effects of eleven histamine HI-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol, 1994,349:140.

二级参考文献20

  • 1[1]Bymaster FP,Calligaro DO,Falcone JF,et al.Radioreceptor binding profile of the atypical antipsychotic olanzapine.Neuropsychopharmacology ,1996,14:87
  • 2[2]Kapur S,Zipursky RB,Remington G,et al.Clinical and theor etical implications of 5-HT2 and D2 receptor occupancy of clozapine,risperi dole,and olanzapine in schizophreia.Am J Psychiatry,1999,156:286
  • 3[3]Arnt J,Skarsfeldt J.Do noval antipsychotics have similar pharmacological characteristics?a review of the evidence.Neuropsychopharmacolog y,1998,16:63
  • 4[4]Bymaster FP.In vivo and in vitro biochemistry of olanzap ine.J Clin Psychiatry,1997,58(suppl 10):28
  • 5[5]Tandon R,Milner K,Jibson MD.Antipsychotics from theory t o practice:integrating clinical and basic data.J Clin Psychiatry,1999,60(suppl 8 ):21
  • 6[6]Beasley CM,Tollefson GD,Tran PV,et al.The efficacy of ol anzapine:the summary of global,multicentral clinical trials.J Clin Psychiatry,19 97,58(suppl 10):7
  • 7[7]Sanger TM,Lieberman JA,Tohen M,et al.Olanzapine versus h aloperidol treatment in first-episode psychosis.Am J Psychiatry,1999,156:79
  • 8[8]Tran PV,Hamilton SH,Runtz AJ,et al.Double-blind compari son of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 9[9]Brier A,Hamilton SH.Comparative efficacy olanzapine and haloperidol for patients with treatmen-resistant schizophrenia.Biol Psychiatry,45:403
  • 10[10] Henderson DC,Nasrallah RA,Goff DC,et al.Switching from clozapin e to olanzapine in treatment-resistant schizophrenia:safety clinical effecacy,a nd predictors of response.J Clin Psychiatry,1998,59:585

共引文献209

同被引文献5

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部